Rationale and conditions for the requirement of chiral bioanalytical methods in bioequivalence studies.
about
Metabolic profiling of praziquantel enantiomers.Bioequivalence requirements in the European Union: critical discussion2017 White Paper on recent issues in bioanalysis: aren't BMV guidance/guidelines 'Scientific'? (Part 1 - LCMS: small molecules, peptides and small molecule biomarkers).Effect of gender and CYP2C9 and CYP2C8 polymorphisms on the pharmacokinetics of ibuprofen enantiomers.A multivariate investigation into the relationship between pharmaceutical characteristics and patient preferences of bioequivalent ibuprofen tablets
P2860
Rationale and conditions for the requirement of chiral bioanalytical methods in bioequivalence studies.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
Rationale and conditions for t ...... ods in bioequivalence studies.
@en
Rationale and conditions for t ...... ods in bioequivalence studies.
@nl
type
label
Rationale and conditions for t ...... ods in bioequivalence studies.
@en
Rationale and conditions for t ...... ods in bioequivalence studies.
@nl
prefLabel
Rationale and conditions for t ...... ods in bioequivalence studies.
@en
Rationale and conditions for t ...... ods in bioequivalence studies.
@nl
P2093
P1476
Rationale and conditions for t ...... hods in bioequivalence studies
@en
P2093
Alfredo García-Arieta
Magí Farré
María Blanco
Pere Roset
P2888
P304
P356
10.1007/S00228-010-0792-7
P577
2010-02-27T00:00:00Z